Class IIOngoingD-0540-2025
Drug recall · July 30, 2025
BENLYSTA recall
Why: CGMP Deviations; potential temperature excursions due to transit delays
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
- Lots / codes
Lot: YK4W, Expiration date: 4/30/2029
- Quantity
- 3 Vials
- Company
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Distribution
- Within the U.S - OH, VA, FL.
- Initiated
- April 21, 2025 · Voluntary: Firm initiated
- Classified
- July 21, 2025
- Reported
- July 30, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.